|
|
Volumn 34, Issue 5, 2002, Pages 1491-1492
|
|
Chronic rejection and graft half-life: Five-year follow-up of the European tacrolimus multicenter renal study
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CORTICOSTEROID DERIVATIVE;
CREATININE;
CYCLOSPORIN;
TACROLIMUS;
IMMUNOSUPPRESSIVE AGENT;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG SAFETY;
FOLLOW UP;
GRAFT SURVIVAL;
HALF LIFE TIME;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY FUNCTION;
KIDNEY GRAFT;
KIDNEY GRAFT REJECTION;
LYMPHOPROLIFERATIVE DISEASE;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
SURVIVAL RATE;
TREATMENT OUTCOME;
ARTICLE;
COMPARATIVE STUDY;
DRUG COMBINATION;
DRUG EFFECT;
EUROPE;
GRAFT REJECTION;
IMMUNOLOGY;
KIDNEY TRANSPLANTATION;
MORTALITY;
RANDOMIZED CONTROLLED TRIAL;
SURVIVAL;
TIME;
COMPARATIVE STUDY;
CYCLOSPORINE;
DRUG THERAPY, COMBINATION;
EUROPE;
FOLLOW-UP STUDIES;
GRAFT REJECTION;
GRAFT SURVIVAL;
HALF-LIFE;
HUMAN;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
POSTOPERATIVE COMPLICATIONS;
SURVIVAL ANALYSIS;
TACROLIMUS;
TIME FACTORS;
HUMANS;
|
|
EID: 0035993620
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)02942-1 Document Type: Conference Paper |
|
Times cited : (62)
|
|
References (9)
|
